Time to rethink aspirin in diabetes?

De Berardis and colleagues’ meta-analysis adds to the growing uncertainty about the role of aspirin in preventing cardiovascular disease in diabetes.1

Despite lack of definitive randomised controlled trial evidence, various guidelines advocate routine use of aspirin on the assumption that diabetic subjects without vascular disease will experience the same clinically …